Clinical Trials Logo

Filter by:
NCT ID: NCT05853523 Completed - Dentin Sensitivity Clinical Trials

The Desensitizing Treatment Effects of the Laser and Ozone on Dentin Hypersensitivity: In-vivo Comparison

Start date: February 27, 2021
Phase: Phase 2
Study type: Interventional

The goal of this split mouth clinical trial is to compare clinical efficacy of diode laser and gas ozone in the treatment of dentine hypersensitivity (DHS) of non-carious-cervical lesion. The main questions it aims to answer are: - gas ozone affects dentine hypersensitivity? - diode laser affects dentine hypersensitivity? Participants, affected of DHS , were treated with gas ozone and diode laser.The pain severity was quantified according to the Visual Analogue Scale (VAS) before and after the treatmens.

NCT ID: NCT05853419 Recruiting - Coronary Disease Clinical Trials

Change History and Adopt a Robotic SolutioN for anGioplasty procedurE

CHANGE
Start date: June 20, 2023
Phase:
Study type: Observational [Patient Registry]

The main objective of the CHANGE registry is the evaluation of the real-world performance and safety profile of the R-One System in PCI.

NCT ID: NCT05853328 Completed - BPPV Clinical Trials

Comparison of EM and SM+ Maneuvers in Patients With BPPV

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Objective of this prospective randomized treatment trial is to compare the effectiveness of the SemontPLUS (SM+) with the Epley maneuver (EM) for the therapy of posterior canal benign paroxysmal positional vertigo canalolithiasis (pcBPPV).

NCT ID: NCT05853302 Recruiting - Clinical trials for Adrenalectomy; Status

Robot-assisted vs Laparoscopic Lateral Transabdominal Adrenalectomy

RvsL-TLA
Start date: December 15, 2022
Phase:
Study type: Observational

This retrospective study evaluates the security and the effectiveness of robotic adrenalectomy when compared to laparoscopic approach in patients who underwent minimally-invasive lateral transperitoneal unilateral adrenalectomy.

NCT ID: NCT05853224 Recruiting - Dermal Filler Clinical Trials

An Interventional Study to Evaluate the Safety and Performance of Crosslinked Hyaluronic Acid Hydrogel

Start date: April 2, 2022
Phase: N/A
Study type: Interventional

The aim of this interventional, pre-market, double- blinded, controlled, two stages study is to evaluate the performance and safety of Crosslinked Hyaluronic Acid (CLHA) Hydrogel (with and without Lidocaine) for the Treatment of Soft Tissue Deficits.

NCT ID: NCT05853198 Recruiting - Clinical trials for PDAC - Pancreatic Ductal Adenocarcinoma

Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability

CASPER
Start date: December 29, 2022
Phase: N/A
Study type: Interventional

The main objective is the evaluation of the prognostic value of ctDNA (circulating tumor DNA) as a marker of surgical futility in patients with operable PDAC.

NCT ID: NCT05852795 Completed - Clinical trials for Autism Spectrum Disorder

Virtual Reality Experiences as Tools to Support Mental Health in Parents of Children With Autism

Mind-VR
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Mindfulness is a technique that involves the intentional and non-judgmental regulation of attention to the present moment, with curiosity, openness, and acceptance, as per its definition. Mindfulness-based interventions (MBIs) have been used to manage mood disorders in various clinical and non-clinical settings, including neurological patients and cardiovascular diseases. Studies have consistently demonstrated that MBIs reduce depressive and anxiety symptoms, as well as rumination. MBIs are considered an alternative and effective treatment for reducing psychological stress in the management of different health conditions. Virtual reality (VR) has recently been proposed as an intermediate interface to help patients with emotional dysregulation learn mindfulness practices. Within this context, new approaches to mental health integrating advanced technologies such as VR can play a critical role. In this interventional study we will seek to demonstrate the effectiveness of a virtual reality-mediated mindfulness-based intervention in a particular group of people who are constantly experiencing psychological distress due to caring for children with autism spectrum disorders (ASD).

NCT ID: NCT05852691 Recruiting - Breast Cancer Clinical Trials

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

Start date: July 18, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of a novel immunotherapy candidate, tobemstomig, in combination with nab-paclitaxel, for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple-negative breast cancer (TNBC).

NCT ID: NCT05852431 Recruiting - Clinical trials for Severe Hypertriglyceridemia

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

ENTRUST
Start date: June 15, 2023
Phase: Phase 3
Study type: Interventional

To determine the effect of Pegozafermin on fasting serum triglyceride levels in subjects with Severe Hypertriglyceridemia (TG ≥500 to ≤2000 mg/dL) after 26 weeks of treatment.

NCT ID: NCT05852223 Recruiting - Clinical trials for Differentiated Thyroid Cancer

Pembrolizumab in High-risk Thyroid Cancer

NePenThe
Start date: April 2024
Phase: Phase 2
Study type: Interventional

This window of opportunity trial is studying a checkpoint inhibitor agent to treat differentiated thyroid cancer in a neoadjuvant setting. A checkpoint inhibitor is a compound aimed at restoring tumor immunosurveillance. The name of this agent is pembrolizumab.